Standard Biotools is trading 6.84% up now at $0.72 in after-hours trading, likely supported by broader market strength.
- No fresh company-specific announcement dated September 3 was identified.
- The S&P 500 rose 0.98% and Nasdaq Composite rose 1.64%.
- The latest material company update was August 5 second-quarter results: $20.1 million revenue, down 7.6% year over year; shares closed at $0.67 on September 3, 2026.